Korro Bio Inc.

NASDAQ: KRRO · Real-Time Price · USD
20.09
0.21 (1.06%)
At close: Aug 15, 2025, 3:08 PM

Korro Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.27M n/a n/a 14.07M
Cost of Revenue
n/a 3.63M 2.51M 3.84M
Gross Profit
2.27M -3.63M -2.51M 10.23M
Operating Income
-91.91M -84.53M -59M -35.49M
Interest Income
n/a n/a 947K 397K
Pretax Income
-83.44M -81.14M -58.02M -21.96M
Net Income
-83.58M -81.17M -58.03M -21.96M
Selling & General & Admin
30.55M 27.28M 16.8M 11.69M
Research & Development
63.64M 57.25M 42.2M 23.8M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
94.18M 84.53M 59M 35.49M
Interest Expense
n/a n/a 118K 764K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
94.18M 84.53M 59M 35.49M
Income Tax Expense
141K 27K 10K 2K
Shares Outstanding (Basic)
8.92M 1.53M 255K 4.45M
Shares Outstanding (Diluted)
8.92M 1.53M 255.17K 4.45M
EPS (Basic)
-9.37 -53.09 -227.58 -4.94
EPS (Diluted)
-9.37 -53.08 -227.42 -4.94
EBITDA
-88.34M -80.9M -56.49M -33.9M
EBIT
-91.91M -84.53M -59M -35.49M
Depreciation & Amortization
3.56M 3.63M 2.51M 1.59M